相关实验视频

Updated: Jul 14, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.8K

纵向早期阿尔茨海默病研究队列中的致病变体

Kelly N H Nudelman1,2, Trever Jackson1, Malia Rumbaugh1

  • 1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|October 6, 2023
PubMed
概括

纵向早期阿尔茨海默病研究 (LEADS) 调查了早期认知障碍的遗传原因. 大多数病例以前没有发现致病变体,这表明新的遗传因素与早期发病的阿尔茨海默病有关.

关键词:
这就是为什么APP APP APP APP.阿尔茨海默病的疾病阿尔茨海默病的疾病.C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9ORF7C9在 GRN GRN GRN 中.马普特 (MAPT) 是一个在PSEN1上.这就是PSEN2的原因.痴呆症 痴呆症是一种痴呆症.这是早期发病的早期发病.遗传学 遗传学 遗传学 是一个测序的测序是指测序的测序.

更多相关视频

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.4K
Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

8.8K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
506
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212